Effect of interferon on 5-fluououracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks

Scott Wadler, Robert Horowitz, Xun Mao, Edward L. Schwartz

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Interferon (IFN) augments the anabolism of 5-fluorouracil (5FU) to its active metabolite, fluorodeoxyuridylate (FdUMP), which inhibits thymidylate synthase (TS). We sought to determine whether this resulted in greater perturbations of nucleotide pools and if so, whether this was associated with an increase in cell lethality, specifically focussing on the lethal cellular lesion, DNA double strand breaks (dsb). To determine whether combination therapy with 5FU + IFN resulted in greater depletion of thymidine nucleotide pools than 5FU alone, a highly sensitive DNA polymerase assay was used. In two human colon cancer cell lines, treatment with 5FU + IFN resulted in a rapid decrease in levels of dTTP by 95%. The addition of IFN to 5FU resulted in greater depletion of dTTP levels over treatment with 5FU alone by up to fourfold, and markedly augmented the dATP/dTTP ratio. The addition of IFN to 5FU had no effect on 5FU-induced perturbations in dCTP, dGTP or dATP pools at 8 and 12 h. Measurement of DNA dsb demonstrated that treatment of HT-29 cells with 10 μM 5FU for 24 h did not increase DNA dsb versus control. The combination of 5FU + 500 U/ml IFN, however, resulted in an increased number of dsb versus both 5FU and untreated control cells (P < 0.01), equivalent to 0.74 ± 0.12 Gy. The addition of IFN to 5FU resulted in a selective further depletion of pools of dTTP and an increase in the number of DNA dsb versus 5FU treatment alone.

Original languageEnglish (US)
Pages (from-to)529-535
Number of pages7
JournalCancer Chemotherapy and Pharmacology
Volume38
Issue number6
DOIs
StatePublished - 1996

Fingerprint

DNA Breaks
Fluorouracil
Interferons
DNA
Double-Stranded DNA Breaks
Fluorodeoxyuridylate
triphosphoric acid
Nucleotides
Thymidylate Synthase
HT29 Cells
DNA-Directed DNA Polymerase
Metabolites
Colonic Neoplasms
Thymidine
Assays

Keywords

  • Biochemical modulation
  • DNA strand breaks
  • Fluorouracil
  • Interferon
  • Nucleotides

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Oncology

Cite this

Effect of interferon on 5-fluououracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks. / Wadler, Scott; Horowitz, Robert; Mao, Xun; Schwartz, Edward L.

In: Cancer Chemotherapy and Pharmacology, Vol. 38, No. 6, 1996, p. 529-535.

Research output: Contribution to journalArticle

@article{bfb491201688441d9e369aed3ea14832,
title = "Effect of interferon on 5-fluououracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks",
abstract = "Interferon (IFN) augments the anabolism of 5-fluorouracil (5FU) to its active metabolite, fluorodeoxyuridylate (FdUMP), which inhibits thymidylate synthase (TS). We sought to determine whether this resulted in greater perturbations of nucleotide pools and if so, whether this was associated with an increase in cell lethality, specifically focussing on the lethal cellular lesion, DNA double strand breaks (dsb). To determine whether combination therapy with 5FU + IFN resulted in greater depletion of thymidine nucleotide pools than 5FU alone, a highly sensitive DNA polymerase assay was used. In two human colon cancer cell lines, treatment with 5FU + IFN resulted in a rapid decrease in levels of dTTP by 95{\%}. The addition of IFN to 5FU resulted in greater depletion of dTTP levels over treatment with 5FU alone by up to fourfold, and markedly augmented the dATP/dTTP ratio. The addition of IFN to 5FU had no effect on 5FU-induced perturbations in dCTP, dGTP or dATP pools at 8 and 12 h. Measurement of DNA dsb demonstrated that treatment of HT-29 cells with 10 μM 5FU for 24 h did not increase DNA dsb versus control. The combination of 5FU + 500 U/ml IFN, however, resulted in an increased number of dsb versus both 5FU and untreated control cells (P < 0.01), equivalent to 0.74 ± 0.12 Gy. The addition of IFN to 5FU resulted in a selective further depletion of pools of dTTP and an increase in the number of DNA dsb versus 5FU treatment alone.",
keywords = "Biochemical modulation, DNA strand breaks, Fluorouracil, Interferon, Nucleotides",
author = "Scott Wadler and Robert Horowitz and Xun Mao and Schwartz, {Edward L.}",
year = "1996",
doi = "10.1007/s002800050522",
language = "English (US)",
volume = "38",
pages = "529--535",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Effect of interferon on 5-fluououracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks

AU - Wadler, Scott

AU - Horowitz, Robert

AU - Mao, Xun

AU - Schwartz, Edward L.

PY - 1996

Y1 - 1996

N2 - Interferon (IFN) augments the anabolism of 5-fluorouracil (5FU) to its active metabolite, fluorodeoxyuridylate (FdUMP), which inhibits thymidylate synthase (TS). We sought to determine whether this resulted in greater perturbations of nucleotide pools and if so, whether this was associated with an increase in cell lethality, specifically focussing on the lethal cellular lesion, DNA double strand breaks (dsb). To determine whether combination therapy with 5FU + IFN resulted in greater depletion of thymidine nucleotide pools than 5FU alone, a highly sensitive DNA polymerase assay was used. In two human colon cancer cell lines, treatment with 5FU + IFN resulted in a rapid decrease in levels of dTTP by 95%. The addition of IFN to 5FU resulted in greater depletion of dTTP levels over treatment with 5FU alone by up to fourfold, and markedly augmented the dATP/dTTP ratio. The addition of IFN to 5FU had no effect on 5FU-induced perturbations in dCTP, dGTP or dATP pools at 8 and 12 h. Measurement of DNA dsb demonstrated that treatment of HT-29 cells with 10 μM 5FU for 24 h did not increase DNA dsb versus control. The combination of 5FU + 500 U/ml IFN, however, resulted in an increased number of dsb versus both 5FU and untreated control cells (P < 0.01), equivalent to 0.74 ± 0.12 Gy. The addition of IFN to 5FU resulted in a selective further depletion of pools of dTTP and an increase in the number of DNA dsb versus 5FU treatment alone.

AB - Interferon (IFN) augments the anabolism of 5-fluorouracil (5FU) to its active metabolite, fluorodeoxyuridylate (FdUMP), which inhibits thymidylate synthase (TS). We sought to determine whether this resulted in greater perturbations of nucleotide pools and if so, whether this was associated with an increase in cell lethality, specifically focussing on the lethal cellular lesion, DNA double strand breaks (dsb). To determine whether combination therapy with 5FU + IFN resulted in greater depletion of thymidine nucleotide pools than 5FU alone, a highly sensitive DNA polymerase assay was used. In two human colon cancer cell lines, treatment with 5FU + IFN resulted in a rapid decrease in levels of dTTP by 95%. The addition of IFN to 5FU resulted in greater depletion of dTTP levels over treatment with 5FU alone by up to fourfold, and markedly augmented the dATP/dTTP ratio. The addition of IFN to 5FU had no effect on 5FU-induced perturbations in dCTP, dGTP or dATP pools at 8 and 12 h. Measurement of DNA dsb demonstrated that treatment of HT-29 cells with 10 μM 5FU for 24 h did not increase DNA dsb versus control. The combination of 5FU + 500 U/ml IFN, however, resulted in an increased number of dsb versus both 5FU and untreated control cells (P < 0.01), equivalent to 0.74 ± 0.12 Gy. The addition of IFN to 5FU resulted in a selective further depletion of pools of dTTP and an increase in the number of DNA dsb versus 5FU treatment alone.

KW - Biochemical modulation

KW - DNA strand breaks

KW - Fluorouracil

KW - Interferon

KW - Nucleotides

UR - http://www.scopus.com/inward/record.url?scp=0029823120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029823120&partnerID=8YFLogxK

U2 - 10.1007/s002800050522

DO - 10.1007/s002800050522

M3 - Article

C2 - 8823494

AN - SCOPUS:0029823120

VL - 38

SP - 529

EP - 535

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 6

ER -